Helix BioPharma Corp. (HBP) — Cash Flow-to-Debt Ratio
Helix BioPharma Corp. (HBP) has a Cash Flow-to-Debt Ratio of -0.41x as of October 2025, meaning its operating cash flow of CA$-1.22 Million could theoretically repay 0% of its total liabilities (CA$3.00 Million) in one year. See Helix BioPharma Corp. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Helix BioPharma Corp. Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Helix BioPharma Corp. across 19 annual periods. Also explore HBP net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Helix BioPharma Corp. (2007–2025)
Year-by-year debt coverage analysis for Helix BioPharma Corp.. For market capitalisation and broader financial context, see Helix BioPharma Corp. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.19x | CA$-3.83 Million | CA$3.22 Million | ▲ +64.0% |
| 2024 | -3.31x | CA$-5.22 Million | CA$1.58 Million | ▼ -12.0% |
| 2023 | -2.95x | CA$-5.53 Million | CA$1.87 Million | ▼ -54.6% |
| 2022 | -1.91x | CA$-6.51 Million | CA$3.41 Million | ▼ -11.9% |
| 2021 | -1.70x | CA$-9.30 Million | CA$5.46 Million | ▲ +69.7% |
| 2020 | -5.62x | CA$-10.83 Million | CA$1.93 Million | ▼ -329.2% |
| 2019 | -1.31x | CA$-5.53 Million | CA$4.22 Million | ▲ +53.4% |
| 2018 | -2.81x | CA$-7.52 Million | CA$2.67 Million | ▲ +33.3% |
| 2017 | -4.22x | CA$-9.29 Million | CA$2.20 Million | ▲ +37.9% |
| 2016 | -6.79x | CA$-8.85 Million | CA$1.30 Million | ▲ +22.5% |
| 2015 | -8.76x | CA$-8.49 Million | CA$969.00K | ▼ -18.7% |
| 2014 | -7.38x | CA$-7.69 Million | CA$1.04 Million | ▲ +10.4% |
| 2013 | -8.24x | CA$-7.81 Million | CA$948.00K | ▲ +18.7% |
| 2012 | -10.14x | CA$-14.11 Million | CA$1.39 Million | ▼ -121.4% |
| 2011 | -4.58x | CA$-10.34 Million | CA$2.26 Million | ▲ +11.6% |
| 2010 | -5.18x | CA$-12.19 Million | CA$2.35 Million | ▲ +11.1% |
| 2009 | -5.83x | CA$-13.16 Million | CA$2.26 Million | ▲ +4.6% |
| 2008 | -6.12x | CA$-7.00 Million | CA$1.14 Million | ▼ -54.8% |
| 2007 | -3.95x | CA$-6.08 Million | CA$1.54 Million | — |